SG171577A1 - Methods for producing yeast-based vaccines - Google Patents
Methods for producing yeast-based vaccinesInfo
- Publication number
- SG171577A1 SG171577A1 SG201101501-3A SG2011015013A SG171577A1 SG 171577 A1 SG171577 A1 SG 171577A1 SG 2011015013 A SG2011015013 A SG 2011015013A SG 171577 A1 SG171577 A1 SG 171577A1
- Authority
- SG
- Singapore
- Prior art keywords
- methods
- yeast
- based vaccines
- producing yeast
- neutral
- Prior art date
Links
- 240000004808 Saccharomyces cerevisiae Species 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 3
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 230000007935 neutral effect Effects 0.000 abstract 2
- 238000012258 culturing Methods 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/064—Saccharomycetales, e.g. baker's yeast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/16—Yeasts; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/035—Fusion polypeptide containing a localisation/targetting motif containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
- C12N2760/18634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US89928107P | 2007-02-02 | 2007-02-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG171577A1 true SG171577A1 (en) | 2011-06-29 |
Family
ID=39682350
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG201101501-3A SG171577A1 (en) | 2007-02-02 | 2008-02-01 | Methods for producing yeast-based vaccines |
| SG10201405420QA SG10201405420QA (en) | 2007-02-02 | 2008-02-01 | Methods for producing yeast-based vaccines |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201405420QA SG10201405420QA (en) | 2007-02-02 | 2008-02-01 | Methods for producing yeast-based vaccines |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US9066893B2 (pl) |
| EP (1) | EP2121013B1 (pl) |
| JP (2) | JP5570819B2 (pl) |
| KR (2) | KR101555641B1 (pl) |
| CN (2) | CN101687030B (pl) |
| AU (1) | AU2008214029B2 (pl) |
| BR (1) | BRPI0807828B8 (pl) |
| CA (1) | CA2676783C (pl) |
| DK (1) | DK2121013T3 (pl) |
| ES (1) | ES2527756T3 (pl) |
| HK (1) | HK1136979A1 (pl) |
| IL (2) | IL200176A (pl) |
| MX (1) | MX2009008175A (pl) |
| PL (1) | PL2121013T3 (pl) |
| PT (1) | PT2121013E (pl) |
| SG (2) | SG171577A1 (pl) |
| SI (1) | SI2121013T1 (pl) |
| WO (1) | WO2008097863A2 (pl) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7465454B2 (en) | 2002-12-16 | 2008-12-16 | Globeimmune, Inc. | Yeast-based vaccines as immunotherapy |
| BRPI0516356A (pt) | 2004-10-18 | 2008-09-02 | Globeimmune Inc | terapia à base de levedura para infecções crÈnicas da hepatite c |
| KR20080043775A (ko) * | 2005-07-11 | 2008-05-19 | 글로브이뮨 | 표적 치료용 회피 돌연변이체에 대한 면역 반응의 유발방법 및 조성물 |
| US20070172503A1 (en) | 2005-12-13 | 2007-07-26 | Mycologics,Inc. | Compositions and Methods to Elicit Immune Responses Against Pathogenic Organisms Using Yeast Based Vaccines |
| CN101448848B (zh) | 2006-03-27 | 2013-12-04 | 全球免疫股份有限公司 | Ras突变及其相关组合物和方法 |
| SG171577A1 (en) | 2007-02-02 | 2011-06-29 | Globeimmune Inc | Methods for producing yeast-based vaccines |
| CN101730542A (zh) * | 2007-03-19 | 2010-06-09 | 环球免疫公司 | 用于靶向消除癌症靶向疗法的突变逃逸的组合物和方法 |
| JP2012503011A (ja) | 2008-09-19 | 2012-02-02 | グローブイミューン，インコーポレイテッド | 慢性ｃ型肝炎ウイルス感染の免疫療法 |
| JP5759980B2 (ja) | 2009-04-17 | 2015-08-05 | グローブイミューン，インコーポレイテッド | 癌および感染症に対する免疫療法組成物の組み合わせ |
| CA2774326C (en) | 2009-09-14 | 2023-11-07 | Donald Bellgrau | Modulation of yeast-based immunotherapy products and responses |
| EP2651439B1 (en) | 2010-12-17 | 2018-09-19 | Globeimmune, Inc. | Compositions and methods for the treatment or prevention of human adenovirus-36 infection |
| PE20140844A1 (es) | 2011-02-12 | 2014-07-14 | Globeimmune Inc | Terapeuticos a base de levadura para infeccion de la hepatitis b cronica |
| RU2619850C2 (ru) | 2011-03-17 | 2017-05-18 | Глоубиммьюн, Инк. | Иммунотерапевтические композиции на основе дрожжей с brachyury |
| CN103732250A (zh) | 2011-06-14 | 2014-04-16 | 全球免疫股份有限公司 | 基于酵母的治疗或预防丁型肝炎病毒感染的组合物和方法 |
| SG10201607663YA (en) | 2011-08-17 | 2016-11-29 | Globeimmune Inc | Yeast-muc1 immunotherapeutic compositions and uses thereof |
| JP6355630B2 (ja) | 2012-06-26 | 2018-07-11 | バイオデシックス・インコーポレイテッドＢｉｏｄｅｓｉｘ Ｉｎｃ | 質量スペクトルを用いて免疫応答発生治療剤で治療する癌患者を選択または除外する方法 |
| MX2015013380A (es) | 2013-03-19 | 2016-01-08 | Globeimmune Inc | Inmunoterapia para cordoma a base de levadura. |
| TWI728239B (zh) | 2013-03-26 | 2021-05-21 | 美商環球免疫公司 | 治療或預防人類免疫缺乏病毒感染之組合物及方法 |
| WO2015031778A2 (en) | 2013-08-30 | 2015-03-05 | Globeimmune, Inc. | Compositions and methods for the treatment or prevention of tuberculosis |
| CN106456677A (zh) | 2014-04-11 | 2017-02-22 | 全球免疫股份有限公司 | 基于酵母的免疫疗法和i型干扰素敏感性 |
| TWI748957B (zh) | 2015-08-03 | 2021-12-11 | 美商環球免疫公司 | 經修飾之酵母-短尾畸型（Ｂｒａｃｈｙｕｒｙ）免疫治療組合物 |
| US20210154250A1 (en) * | 2018-05-15 | 2021-05-27 | Globeimmune, Inc. | Lysates of recombinant yeast for inducing cellular immune responses |
| US11311603B2 (en) | 2018-06-19 | 2022-04-26 | Nantcell, Inc. | HIV treatment compositions and methods |
| WO2020061203A1 (en) | 2018-09-21 | 2020-03-26 | Nantcell, Inc. | Methods and compositions for modulating myeloid-derived suppressor cells |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2486400B1 (fr) | 1980-07-09 | 1986-05-30 | Univablot | Medicaments a base de levures ou de leurs extraits insolubles |
| NZ199722A (en) | 1981-02-25 | 1985-12-13 | Genentech Inc | Dna transfer vector for expression of exogenous polypeptide in yeast;transformed yeast strain |
| US4775622A (en) | 1982-03-08 | 1988-10-04 | Genentech, Inc. | Expression, processing and secretion of heterologous protein by yeast |
| US5310654A (en) | 1985-07-31 | 1994-05-10 | The Board Of Trustees Of The Leland Stanford Junior University | Method for determining virulence of Yersinia |
| US5234830A (en) | 1988-02-03 | 1993-08-10 | Suntory Limited | DNA encoding a KEX2 endoprotease without a C-terminal hydrophobic region |
| IL95019A0 (en) | 1989-08-09 | 1991-06-10 | Mycogen Corp | Process for encapsulation of biologicals |
| JP3510639B2 (ja) * | 1991-06-28 | 2004-03-29 | カルピス株式会社 | インターロイキン産生能を調節する機能を持たせた機能性食品又は健康食品 |
| JP3091851B2 (ja) | 1992-11-06 | 2000-09-25 | 工業技術院長 | 哺乳類の高マンノース型糖蛋白質糖鎖の酵母による製造法 |
| US5830463A (en) | 1993-07-07 | 1998-11-03 | University Technology Corporation | Yeast-based delivery vehicles |
| US5413914A (en) | 1993-07-07 | 1995-05-09 | The Regents Of The University Of Colorado | Yeast assay to identify inhibitors of dibasic amino acid processing endoproteases |
| US5858378A (en) | 1996-05-02 | 1999-01-12 | Galagen, Inc. | Pharmaceutical composition comprising cryptosporidium parvum oocysts antigen and whole cell candida species antigen |
| WO1998035049A1 (fr) | 1997-02-07 | 1998-08-13 | Oriental Yeast Co., Ltd. | Disulfure-isomerase de proteine de levure recombinee et son procede de preparation |
| GB9902000D0 (en) | 1999-01-30 | 1999-03-17 | Delta Biotechnology Ltd | Process |
| ATE319475T1 (de) | 2000-04-06 | 2006-03-15 | Seer Pharmaceuticals Llc | Microbielles wirkstoffabgabesystem |
| AU2002225681A1 (en) | 2000-11-15 | 2002-05-27 | Globe Immune, Inc. | Yeast-dentritic cell vaccines and uses thereof |
| JP4288862B2 (ja) | 2001-03-30 | 2009-07-01 | トヨタ自動車株式会社 | プレニルアルコールの製造方法 |
| US8343502B2 (en) | 2002-12-16 | 2013-01-01 | Globeimmune, Inc. | Yeast-based vaccines as immunotherapy |
| US7439042B2 (en) | 2002-12-16 | 2008-10-21 | Globeimmune, Inc. | Yeast-based therapeutic for chronic hepatitis C infection |
| US7465454B2 (en) | 2002-12-16 | 2008-12-16 | Globeimmune, Inc. | Yeast-based vaccines as immunotherapy |
| KR100507665B1 (ko) | 2003-03-25 | 2005-08-10 | 김경숙 | 페리틴 이형집합체를 효모 내에서 발현시키기 위한 벡터 및 상기 발현벡터로 형질전환 시킨 재조합 효모 |
| BRPI0516356A (pt) | 2004-10-18 | 2008-09-02 | Globeimmune Inc | terapia à base de levedura para infecções crÈnicas da hepatite c |
| JP4904086B2 (ja) | 2005-05-25 | 2012-03-28 | 公益財団法人微生物化学研究会 | クラゲ類の分解廃液の処理装置及び処理方法、並びに微生物 |
| KR20080043775A (ko) | 2005-07-11 | 2008-05-19 | 글로브이뮨 | 표적 치료용 회피 돌연변이체에 대한 면역 반응의 유발방법 및 조성물 |
| US20070172503A1 (en) | 2005-12-13 | 2007-07-26 | Mycologics,Inc. | Compositions and Methods to Elicit Immune Responses Against Pathogenic Organisms Using Yeast Based Vaccines |
| US7736642B2 (en) | 2006-02-02 | 2010-06-15 | Globeimmune, Inc. | Yeast-based vaccine for inducing an immune response |
| CN101448848B (zh) | 2006-03-27 | 2013-12-04 | 全球免疫股份有限公司 | Ras突变及其相关组合物和方法 |
| SG171577A1 (en) | 2007-02-02 | 2011-06-29 | Globeimmune Inc | Methods for producing yeast-based vaccines |
| CN101730542A (zh) | 2007-03-19 | 2010-06-09 | 环球免疫公司 | 用于靶向消除癌症靶向疗法的突变逃逸的组合物和方法 |
| JP2012503011A (ja) | 2008-09-19 | 2012-02-02 | グローブイミューン，インコーポレイテッド | 慢性ｃ型肝炎ウイルス感染の免疫療法 |
| WO2010065626A1 (en) | 2008-12-02 | 2010-06-10 | Globeimmune, Inc. | Genotyping tools, methods and kits |
| JP5759980B2 (ja) | 2009-04-17 | 2015-08-05 | グローブイミューン，インコーポレイテッド | 癌および感染症に対する免疫療法組成物の組み合わせ |
| CA2774326C (en) | 2009-09-14 | 2023-11-07 | Donald Bellgrau | Modulation of yeast-based immunotherapy products and responses |
| EP2547792A4 (en) | 2010-03-14 | 2013-11-27 | Globeimmune Inc | PHARMACOGENOMIC TREATMENT AND ADAPTATION TO THE RESPONSE OF AN INFECTIOUS DISEASE USING YEAST IMMUNOTHERAPY |
-
2008
- 2008-02-01 SG SG201101501-3A patent/SG171577A1/en unknown
- 2008-02-01 US US12/525,045 patent/US9066893B2/en active Active
- 2008-02-01 DK DK08714176.8T patent/DK2121013T3/en active
- 2008-02-01 CN CN200880010797.6A patent/CN101687030B/zh active Active
- 2008-02-01 JP JP2009548478A patent/JP5570819B2/ja active Active
- 2008-02-01 BR BRPI0807828A patent/BRPI0807828B8/pt active IP Right Grant
- 2008-02-01 CA CA2676783A patent/CA2676783C/en active Active
- 2008-02-01 MX MX2009008175A patent/MX2009008175A/es active IP Right Grant
- 2008-02-01 KR KR1020097017916A patent/KR101555641B1/ko active IP Right Grant
- 2008-02-01 PT PT87141768T patent/PT2121013E/pt unknown
- 2008-02-01 ES ES08714176.8T patent/ES2527756T3/es active Active
- 2008-02-01 PL PL08714176T patent/PL2121013T3/pl unknown
- 2008-02-01 KR KR1020147033308A patent/KR20150006022A/ko not_active Application Discontinuation
- 2008-02-01 WO PCT/US2008/052843 patent/WO2008097863A2/en active Application Filing
- 2008-02-01 AU AU2008214029A patent/AU2008214029B2/en active Active
- 2008-02-01 CN CN201410244501.4A patent/CN104120086A/zh not_active Withdrawn
- 2008-02-01 SG SG10201405420QA patent/SG10201405420QA/en unknown
- 2008-02-01 SI SI200831360T patent/SI2121013T1/sl unknown
- 2008-02-01 EP EP08714176.8A patent/EP2121013B1/en active Active
-
2009
- 2009-07-30 IL IL200176A patent/IL200176A/en active IP Right Grant
-
2010
- 2010-05-24 HK HK10105007.8A patent/HK1136979A1/xx unknown
-
2013
- 2013-03-13 US US13/798,725 patent/US9549970B2/en active Active
-
2014
- 2014-06-25 JP JP2014129979A patent/JP2014223072A/ja not_active Withdrawn
-
2015
- 2015-02-25 IL IL237406A patent/IL237406A0/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG171577A1 (en) | Methods for producing yeast-based vaccines | |
| AU2019268194A1 (en) | Cell culture system | |
| WO2010078457A3 (en) | Methods of producing isoprene and a co-product | |
| UA92157C2 (ru) | Способ продуцирования гормона роста | |
| AU2016204319A1 (en) | Methods and compositions for producing squalene using yeast | |
| WO2010096588A3 (en) | Cell culture media containing combinations of proteins | |
| MY156588A (en) | Systems using cell culture for production of isoprene | |
| NZ602201A (en) | A novel ethanologenic clostridium species, clostridium coskatii | |
| MX2007010045A (es) | Pirazolopirimidinas. | |
| NO20080001L (no) | Fremgangsmate til fremstilling av av 1,3-propanediol fra glycerol, et biprodukt fra fremstilling av biodiesel | |
| IL190322A (en) | Nutritional substrate for cell culture culture | |
| EA200900286A1 (ru) | Модификация бактерий для получения этанола | |
| WO2009140452A3 (en) | Isolation of stem cell precursors and expansion in non-adherent conditions | |
| BR112012029271A2 (pt) | fungo isolado, método para produzir e kit para fabricar pelo menos um composto selecionado do grupo que consite de 1, 8-cineol, 1-metil-1,4-cicloexadieno, e (+) -a-metileno-a-fenchocanforona, molécula de ácido nucleico isolada de um fungo,e, método para gerar cepas mutantes de um fungo. | |
| WO2004050709A3 (en) | Charged cyclodextrin derivatives and their use in plant cell and tissue culture growth media | |
| DE502005006003D1 (de) | Verfahren zur herstellung einer epithelzellen enthaltenden zellzusammensetzung | |
| TW200506059A (en) | Method for obtaining mastocyte lines from pig tissues and for producing heparin-type molecules | |
| MX2009007790A (es) | Mejora del crecimiento celular. | |
| ATE550944T1 (de) | Pilzstämme und ein verfahren zur herstellung eines insektizids von diesen stämmen | |
| WO2018183848A8 (en) | Media for microorganism culture and related compositions and methods | |
| WO2008002152A3 (en) | Process for culturing bacteria of the piscirickettsia genus | |
| TW200617165A (en) | Process for preparing a conditioned medium of astrocyte-like cells | |
| UA100849C2 (ru) | Способ репликации вируса гриппа в культуре | |
| TW200833838A (en) | Improved methods for producing yeast-based vaccines | |
| TW200728267A (en) | Processes and intermediates for the preparation of prostaglandins |